Alternatives Research & Development Foundation (ARDF) awarded grants totaling nearly $280,000 to seven projects that are developing alternatives to reduce or replace the use of animals in research and testing.
This week, AAVS affiliate, the Alternatives Research & Development Foundation (ARDF) awarded grants totaling nearly $280,000 to seven projects that are developing alternatives to reduce or replace the use of animals in research and testing. The work done by this year’s grantees is particularly exciting and addresses important biomedical issues.
For example, two studies are developing models to study COVID-19, without the use of animals. With the hope to discover successful drug treatments, other projects are focused on developing alternatives using human tissue that model heart function and bone formation, as well as non-animal methods to screen drugs against acute myeloid leukemia.
Two projects are developing alternatives to address uses
of animals that are not widely known, such as the use of mice to test stem
cells and their ability to morph into different tissue types and the use of
kittens and mice to culture and harvest the Toxoplasma gondii parasite,
which causes food-borne illnesses.
ARDF is one of AAVS’s most distinctive initiatives because it directly
supports the development of alternatives that solve the problems of animal
testing—one grant at a time. Since 1993, through the generosity of our
supporters, ARDF has provided over $3.75 million to fund projects that focus
on replacing the use of animals in research, testing, and education.
For more, vivist Alternatives Research & Development Foundation (ARDF).
Return to Alternatives to Animal Testing, Experimentation and Dissection
Read more at COVID-19/Coronavirus Articles Directory